
Micrima Ltd. Redefining Breast Cancer Diagnostics
At Micrima, we are transforming breast tissue analysis to empower earlier, more personalised breast cancer diagnosis. Our innovative Mi~Scan® technology uses safe, non-ionising radio waves and AI to measure breast tissue properties—quickly, safely, and without compression, in any location. Our Mi~Score® product takes Mi~Scan® data and produces breast density maps, trending and direct integration with existing breast cancer risk models. By delivering immediate insights into breast density and tissue type, we enable tailored diagnostic pathways and enhanced risk profiling for women of all ages. Our mission is to make advanced breast health data accessible to support informed, proactive care. With Micrima, clinicians gain vital tools to improve outcomes—and women gain the knowledge they need to take control of their breast health.
Breast Cancer: Early Detection Saves Lives
1 in 7 women will be diagnosed with breast cancer in their lifetime.
When caught early, survival rates can be as high as 100%.
Yet 34% of cases are only detected after the cancer has spread, when treatment is harder and survival rates drop significantly.
Mi~Scan® from Micrima
Give your employees the power of knowledge. Mi~Scan® is a fast, non-invasive breast cancer risk and density scan that delivers results without discomfort, radiation, or long wait times.
Why make it part of your employee benefits?
Promotes individual health and wellbeing.
Demonstrates your organisation’s commitment to equality, inclusion, and long-term care.
Empowers your female workforce with vital information about their breast health and risk factors.
Visit our stand to see how Mi~Scan® can help you create a healthier, more supported workforce — and show your employees you truly care.
Two Glass Wharf
2022 Sponsors